Matches in Wikidata for { <http://www.wikidata.org/entity/Q69007843> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q69007843 description "1987 թվականի հունվարի 1-ին հրատարակված գիտական հոդված" @default.
- Q69007843 description "artikull shkencor i botuar më 01 janar 1987" @default.
- Q69007843 description "artículu científicu espublizáu en xineru de 1987" @default.
- Q69007843 description "bài báo khoa học" @default.
- Q69007843 description "im Januar 1987 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69007843 description "scientific article published on 01 January 1987" @default.
- Q69007843 description "wetenschappelijk artikel" @default.
- Q69007843 description "наукова стаття, опублікована в січні 1987" @default.
- Q69007843 name "Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?" @default.
- Q69007843 name "Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?" @default.
- Q69007843 name "Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?" @default.
- Q69007843 type Item @default.
- Q69007843 label "Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?" @default.
- Q69007843 label "Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?" @default.
- Q69007843 label "Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?" @default.
- Q69007843 prefLabel "Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?" @default.
- Q69007843 prefLabel "Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?" @default.
- Q69007843 prefLabel "Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?" @default.
- Q69007843 P1433 Q69007843-81B09FEA-6FF9-4573-BA77-2C04D28DFB13 @default.
- Q69007843 P1476 Q69007843-E0E76A79-C340-4AD6-BD76-58BE3BBB1E8D @default.
- Q69007843 P2093 Q69007843-6FC50E19-BCC6-4D5B-818C-BFEB962CF2D9 @default.
- Q69007843 P2093 Q69007843-80CD96E3-8C21-46A2-B032-35492F9923DB @default.
- Q69007843 P2093 Q69007843-F48A99D6-7D4C-43DC-995C-744914B97E08 @default.
- Q69007843 P304 Q69007843-77BFAC53-AA4C-4532-854D-6C65D33E42C6 @default.
- Q69007843 P31 Q69007843-D3BBEAAB-475A-4D7E-AB23-8EA0DE3326D5 @default.
- Q69007843 P433 Q69007843-43C620BD-FC2F-41B5-9C00-4C531F613AE7 @default.
- Q69007843 P478 Q69007843-32EEC2C4-3CC6-4A73-AC16-40D54860F108 @default.
- Q69007843 P50 Q69007843-426202E2-3DC7-4B43-9B6F-C1ED35ABDED7 @default.
- Q69007843 P50 Q69007843-C4AEE0E3-6AE6-49F3-98DA-0A5F0074C785 @default.
- Q69007843 P577 Q69007843-83A4789A-1C32-4DA1-8B2C-E14AAFBDDBB6 @default.
- Q69007843 P698 Q69007843-3E2082CE-B80E-4962-8448-5F5F71DAFC78 @default.
- Q69007843 P921 Q69007843-5B3F0DA9-A62C-4E87-BBDC-AA9838518896 @default.
- Q69007843 P698 2444513 @default.
- Q69007843 P1433 Q27710898 @default.
- Q69007843 P1476 "Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?" @default.
- Q69007843 P2093 "Dabrowska M" @default.
- Q69007843 P2093 "Wołosowicz N" @default.
- Q69007843 P2093 "Wysocka J" @default.
- Q69007843 P304 "390-397" @default.
- Q69007843 P31 Q13442814 @default.
- Q69007843 P433 "3" @default.
- Q69007843 P478 "114" @default.
- Q69007843 P50 Q19826267 @default.
- Q69007843 P50 Q29413866 @default.
- Q69007843 P577 "1987-01-01T00:00:00Z" @default.
- Q69007843 P698 "2444513" @default.
- Q69007843 P921 Q808845 @default.